TerrAscend (TSNDF) Non-Current Assets (2021 - 2026)

TerrAscend's (TSNDF) quarterly Non-Current Assets came in at $446.7 million in Q1 2026, down 10.59% year-on-year from $499.5 million in Q1 2025, and little changed on a QoQ basis from $447.3 million in Q4 2025.

TerrAscend (TSNDF) Non-Current Assets (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Non-Current Assets data on file, last reported at $446.7 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 10.59% year-over-year to $446.7 million in Q1 2026; TTM through Mar 2026 was $446.7 million, a 10.59% decrease from a year earlier, with the FY2025 full-year figure at $447.3 million, up 3.93% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $446.7 million, roughly flat from $447.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for TSNDF reached as high as $871.3 million in Q2 2022 and fell as low as $430.3 million in Q4 2024.
  • Historically, Non-Current Assets has averaged $568.8 million across 5 years, with a median of $557.9 million in 2024.
  • Across the five-year window, Non-Current Assets soared 41.56% in 2022 and slumped 30.79% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $579.6 million in 2022, then slipped by 2.75% to $563.6 million in 2023, then decreased by 23.65% to $430.3 million in 2024, then grew by 3.93% to $447.3 million in 2025, then retreated by 0.14% to $446.7 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $446.7 million in Q1 2026, $447.3 million in Q4 2025, and $435.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 446.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 446.66 Mn
Dec 31, 2025 447.27 Mn
Sep 30, 2025 435.90 Mn
Jun 30, 2025 438.92 Mn
Mar 31, 2025 499.54 Mn
Dec 31, 2024 430.34 Mn
Sep 30, 2024 551.22 Mn
Jun 30, 2024 555.44 Mn
Mar 31, 2024 557.88 Mn
Dec 31, 2023 563.63 Mn
Sep 30, 2023 627.45 Mn
Jun 30, 2023 615.12 Mn
Mar 31, 2023 587.79 Mn
Dec 31, 2022 579.59 Mn
Sep 30, 2022 612.09 Mn
Jun 30, 2022 871.30 Mn
Mar 31, 2022 849.27 Mn
Dec 31, 2021 409.45 Mn